| Trial Vendor Associate Director |
Dublin (NOCC) |
Ireland |
Development |
Innovative Medicines |
Research & Development |
11月 06, 2024 |
| Regulatory Compliance Project Specialist |
Dublin (Country President Office (CPO)) |
Ireland |
Development |
Innovative Medicines |
Research & Development |
11月 06, 2024 |
| Global Labelling Manager |
Dublin (NOCC) |
Ireland |
Development |
Innovative Medicines |
Research & Development |
11月 05, 2024 |
| Global Regulatory Publishing Associate |
Dublin (NOCC) |
Ireland |
Development |
Innovative Medicines |
Research & Development |
11月 04, 2024 |
| Site HSE Head & Cluster Lead |
Dublin (NOCC) |
Ireland |
Operations |
CTS |
Facilities & Administration |
11月 01, 2024 |
| Study Leader |
Dublin (NOCC) |
Ireland |
Development |
Innovative Medicines |
Research & Development |
10月 31, 2024 |
| Associate Director RWE Manager |
Dublin (NOCC) |
Ireland |
Operations |
CTS |
Market Access |
10月 25, 2024 |
| Pricing Manager |
Dublin (Country President Office (CPO)) |
Ireland |
International |
CTS |
Market Access |
10月 16, 2024 |
| Central Integrated Scientific Review Committee Lead |
Dublin (NOCC) |
Ireland |
Development |
Innovative Medicines |
Research & Development |
10月 14, 2024 |
| Associate Director, Clinical Processes & Solutions |
Dublin (NOCC) |
Ireland |
Development |
Innovative Medicines |
Research & Development |
10月 14, 2024 |
| Clinical Document Management - Business Migrations Manager |
Dublin (NOCC) |
Ireland |
Development |
Innovative Medicines |
Research & Development |
10月 02, 2024 |
| Principal Clinical Data Manager |
Dublin (NOCC) |
Ireland |
Development |
Innovative Medicines |
Research & Development |
9月 26, 2024 |
| Director Quantitative Safety Scientist |
Dublin (NOCC) |
Ireland |
Development |
Innovative Medicines |
Research & Development |
9月 17, 2024 |
| Real World Evidence Research Analyst |
Dublin (NOCC) |
Ireland |
Operations |
CTS |
Market Access |
8月 12, 2024 |
| Senior Medical Information Manager 2 |
Dublin (NOCC) |
Ireland |
Operations |
CTS |
Research & Development |
4月 23, 2024 |